Published on
June 20, 2019
- 12:00 GMT
OPKO Health Submits De Novo Request to the U.S. FDA for the 4Kscore® Test
MIAMI, June 20, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces that the Company has submitted a de novo request to the U.S. Food and Drug Administration (FDA) seeking regulatory clearance for the 4Kscore® test. The 4Kscore® test is a …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
